ストックスクリーナーアプリを入手
4.04
0.00%
0.00
アフターアワーズ：
4.04
前日終値:
$4.04
開ける：
$4.02
24時間の取引高:
857.46K
Relative Volume:
0.34
時価総額：
$335.89M
収益：
$103.00K
当期純損益:
$-42.47M
株価収益率:
-2.1263
EPS:
-1.9
ネットキャッシュフロー:
$-34.30M
1週間 パフォーマンス:
+0.75%
1か月 パフォーマンス:
-0.74%
6か月 パフォーマンス:
+27.04%
1年 パフォーマンス:
+176.71%
1日の値動き範囲:
$4.02
$4.04
1週間の範囲:
$4.01
$4.04
52週間の値動き範囲:
$1.38
$4.50
Checkpoint Therapeutics Inc Stock (CKPT) Company Profile
名前
Checkpoint Therapeutics Inc
セクター
電話
781-652-4500
住所
95 SAWYER ROAD, WALTHAM, NY
CKPT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
CKPT
Checkpoint Therapeutics Inc
|
4.04 | 335.89M | 103.00K | -42.47M | -34.30M | -1.90 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Checkpoint Therapeutics Inc Stock (CKPT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-01-13 | 開始されました | D. Boral Capital | Buy |
| 2022-07-14 | 再開されました | B. Riley Securities | Buy |
| 2021-06-09 | 開始されました | B. Riley Securities | Buy |
| 2021-01-20 | 開始されました | Cantor Fitzgerald | Overweight |
| 2019-05-29 | 開始されました | Lake Street | Buy |
| 2017-12-08 | 開始されました | H.C. Wainwright | Buy |
すべてを表示
Checkpoint Therapeutics Inc (CKPT) 最新ニュース
2025-04-19 | SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, CKPT, QTRX, AKYA on Behalf of Shareholders | NDAQ:CKPT | Press Release - Stockhouse
$TOCKHOLDER ALERT: The M&A Class Action Firm Continues Its Investigation Into The MergerBRDG, AKYA, CKPT, QTRX - Longview News-Journal
Checkpoint therapeutics CFO Garrett Gray sells $49,904 in stock By Investing.com - Investing.com South Africa
High Growth Tech Stocks in the US for April 2025 - simplywall.st
3 Growth Companies Insiders Are Betting On - Yahoo Finance
Checkpoint Therapeutics CEO sells stock for $60,963 By Investing.com - Investing.com Canada
Checkpoint therapeutics CFO Garrett Gray sells $49,904 in stock - Investing.com India
Checkpoint Therapeutics Executives Sell Shares for Tax Obligations - TradingView
Checkpoint Therapeutics CEO sells stock for $60,963 - Investing.com
Fortress Biotech Reports 2024 Financial Results and Recent Corporate Highlights - The Manila Times
Fortress Biotech Transforms Portfolio: Dual FDA Wins, $28M Deal, Latest Earnings - Stock Titan
Fortress Biotech Inc. (FBIO) reports earnings - qz.com
Checkpoint Therapeutics Full Year 2024 Earnings: US$1.42 loss per share (vs US$1.87 loss in FY 2023) - Yahoo Finance
Checkpoint Therapeutics Reports 2024 Financial Results and Merger - TipRanks
Checkpoint Therapeutics Inc. (CKPT) reports earnings - Quartz
Checkpoint Therapeutics, Inc. SEC 10-K Report - TradingView
Checkpoint Therapeutics Inc reports results for the quarter ended December 31Earnings Summary - TradingView
Checkpoint Therapeutics Reports Full-Year 2024 Financial Results and Recent Corporate Updates - The Manila Times
Breakthrough: CKPT Secures FDA Approval and $416M Merger Deal in Transformative Year - Stock Titan
GLAZER CAPITAL, LLC Acquires Significant Stake in Checkpoint The - GuruFocus
Beryl Capital Management LLC's Strategic Acquisition of Checkpoi - GuruFocus.com
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BRDG, CMRX, WBA, CKPT on Behalf of Shareholders - Morningstar
Checkpoint Therapeutics, Inc.'s (NASDAQ:CKPT) Shift From Loss To Profit - Yahoo
Sun Pharma shares in focus as co to acquire Checkpoint Therapeutics for $355 million - MSN
CHECKPOINT INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Checkpoint Therapeutics, Inc.CKPT - Business Wire
Sun Pharma To Acquire Nasdaq-Listed Checkpoint Therapeutics For $355 Million - MSN
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options - GlobeNewswire
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of ... - Bluefield Daily Telegraph
SHAREHOLDER ALERT: Kaskela Law LLC Announces Shareholder Investigation into Fairness of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) Buyout Offer and Encourages Investors to Contact the Firm to Discuss Their Legal Rights and Options - GlobeNewswire Inc.
10,081 Shares in Checkpoint Therapeutics, Inc. (NASDAQ:CKPT) Bought by SBI Securities Co. Ltd. - Defense World
Sun Pharma is betting big on speciality. Will it pay off? | Stock Market News - Mint
How Acquiring Checkpoint Therapeutics Inc Adds Value to Sun Pharma? - Smartkarma
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Checkpoint Therapeutics, Inc. (NasdaqCKPT), Redfin Corporation (NasdaqRDFN), Amplify Energy Corp. (NYSEAMPY), Blackboxstocks Inc. (NasdaqBL - Morningstar
Sun Pharma to Acquire Checkpoint Therapeutics in Oncology Expansion - Chemical Industry Digest
Checkpoint Therapeutics’ (CKPT) “Neutral” Rating Reaffirmed at HC Wainwright - Defense World
Checkpoint Therapeutics Target of Unusually Large Options Trading (NASDAQ:CKPT) - Defense World
This Lennar Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday - Benzinga
Major Acquisition Deal in Pharmaceutical Industry: Sun Pharma to Acquire Checkpoint Therapeutics - Dalal Street Investment Journal
Sun Pharma to acquire Checkpoint Therapeutics Inc for up to USD 355 mn - Press Trust of India
Sun Pharma shares rise over 2 pc as company to acquire Checkpoint Therapeutics - Press Trust of India
3 Penny Stocks to Watch Now, 11/3/25 - TipRanks
Checkpoint Therapeutics (NASDAQ:CKPT) Receives Hold Rating from Lake Street Capital - Defense World
Sun Pharma surges 3%. 3 reasons why Motilal Oswal has ‘Buy’ rating - The Financial Express
Sun Pharma to acquire oncology therapy company Checkpoint in US - domain-b.com
Checkpoint Therapeutics (NASDAQ:CKPT) Given Buy Rating at D. Boral Capital - Defense World
Sun Pharma to acquire a US-based oncology firm in a deal exceeding ₹3,000 crore - Bizz Buzz
Despite near-term challenges, brokerages remain positive on Sun Pharma - Business Standard
Sun Pharma to acquire US oncology compony for over Rs 3,000 crore - MSN
CKPT Merger Alert: Checkpoint Shareholders Seeking Money Should Contact Julie & Holleman Regarding Sale to Sun Pharma - Longview News-Journal
Checkpoint Therapeutics gets picked up by Sun Pharma, enjoys 60% share bump - Mugglehead Magazine
Checkpoint Therapeutics Inc (CKPT) 財務データ
収益
当期純利益
現金流量
EPS
0.15%
4.32%
大文字化:
|
ボリューム (24 時間):